In vitro and in vivo studies have demonstrated that EGFR activation can initiate multiple pathological processes leading to DKD, such as hemodynamic and metabolic alterations, chronic inflammation, and multicellular dysfunction (Figure 1 and Table 1). This evidence concerns the gene EGFR and diabetic kidney disease.